BIM(EL) is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine

ABSTRACTS: BACKGROUND: Arsenic trioxide (ATO) is reported to be an effective therapeutic agent in acute promyelocytic leukemia (APL) through inducing apoptotic cell death. Buthionine sulfoximine (BSO), an oxidative stress pathway modulator, is suggested as a potential combination therapy for ATO-ins...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tanaka, Yukie, Komatsu, Takayuki, Shigemi, Hiroko, Yamauchi, Takahiro, Fujii, Yutaka
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029189/
https://ncbi.nlm.nih.gov/pubmed/24428916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-27
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados